David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOCU
3251
PUT
DocuSign
DOCU
$12.2B
| $1.15M | ﹤0.01% |
24,200
+6,200
| +34% | +$317K |
|
3252
Expensify
EXFY
$233M
| $1.15M | ﹤0.01% |
1,318,100
-30,650
| -2% | -$36.4K |
|
3253
Southern California Bancorp
BCAL
$687M
| $1.15M | ﹤0.01% |
64,673
-20,056
| -24% | -$367K |
|
3254
Compass Minerals
CMP
$1.04B
| $1.14M | ﹤0.01% |
49,026
+1,503
| +3% | +$35.4K |
|
3255
PUT
Insperity
NSP
$1.99B
| $1.14M | ﹤0.01% |
+42,300
| New | +$1.36M |
|
3256
PUT
Five Below
FIVE
$13.8B
| $1.14M | ﹤0.01% |
5,000
-33,300
| -87% | -$6.97M |
|
3257
CALL
American Tower
AMT
$81.4B
| $1.14M | ﹤0.01% |
6,600
-9,300
| -58% | -$1.67M |
|
3258
PUT
Sibanye-Stillwater
SBSW
$8.71B
| $1.14M | ﹤0.01% |
+92,300
| New | +$1.44M |
|
3259
Shinhan Financial Group
SHG
$36.6B
| $1.14M | ﹤0.01% |
18,544
-16,428
| -47% | -$1.01M |
|
3260
Cytek Biosciences
CTKB
$616M
| $1.14M | ﹤0.01% |
260,125
-3,001
| -1% | -$14.2K |
|
3261
CALL
Piper Sandler
PIPR
$5.31B
| $1.13M | ﹤0.01% |
14,800
-15,200
| -51% | -$1.25M |
|
|
TTAN
3262
ServiceTitan Inc
TTAN
$9.54B
| $1.13M | ﹤0.01% |
17,808
+1,392
| +8% | +$107K |
|
3263
CALL
Vital Farms
VITL
$440M
| $1.13M | ﹤0.01% |
80,000
+21,600
| +37% | +$510K |
|
3264
Metallus
MTUS
$821M
| $1.13M | ﹤0.01% |
68,998
-5,900
| -8% | -$108K |
|
3265
Treace Medical Concepts
TMCI
$293M
| $1.13M | ﹤0.01% |
841,269
+211,139
| +34% | +$421K |
|
|
DRUG
3266
Bright Minds Biosciences
DRUG
$735M
| $1.13M | ﹤0.01% |
15,445
+11,528
| +294% | +$928K |
|
3267
Santander
BSBR
$43B
| $1.13M | ﹤0.01% |
+189,738
| New | +$1.21M |
|
|
ONL
3268
Orion Office REIT
ONL
$163M
| $1.12M | ﹤0.01% |
521,574
-70,383
| -12% | -$163K |
|
|
FLG
3269
Flagstar Bank National Association
FLG
$5.58B
| $1.12M | ﹤0.01% |
85,145
-157,322
| -65% | -$2.06M |
|
3270
Lindsay Corp
LNN
$1.16B
| $1.12M | ﹤0.01% |
9,415
-2,208
| -19% | -$280K |
|
|
FFWM
3271
DELISTED
First Foundation Inc
FFWM
| $1.12M | ﹤0.01% |
189,547
-214,321
| -53% | -$1.3M |
|
3272
Pinduoduo
PDD
$119B
| $1.12M | ﹤0.01% |
+10,940
| New | +$1.15M |
|
3273
PUT
Floor & Decor
FND
$5.72B
| $1.12M | ﹤0.01% |
22,000
-80,400
| -79% | -$5.23M |
|
3274
Algoma Steel
ASTL
$447M
| $1.12M | ﹤0.01% |
270,544
-252,714
| -48% | -$1.1M |
|
3275
iShares MSCI Israel ETF
EIS
$913M
| $1.12M | ﹤0.01% |
9,617
-1,173
| -11% | -$141K |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.